Results 261 to 270 of about 3,265,974 (326)

Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. [PDF]

open access: yes, 1970
Amemiya, H   +9 more
core  

Hollow Polymer Droplets and Capsules Formed by Nonsolvent‐Induced Phase Separation

open access: yesAdvanced Physics Research, EarlyView.
Simulation snapshots illustrate the evolution of a polymer‐solvent droplet in a nonsolvent bath: 1) initial homogeneous droplet state, 2) intermediate stage with droplet shrinkage, skin formation, and macrophase‐separation onset, and 3) late stage with coarsened nonsolvent‐rich domains forming a hollow microparticle. Abstract Using large‐scale particle‐
Niklas Blagojevic   +3 more
wiley   +1 more source

Atypical Postoperative Bleeding as a First Manifestation of Acquired Hemophilia A: A Case Report. [PDF]

open access: yesClin Med Insights Case Rep
Michalak M   +3 more
europepmc   +1 more source

Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities

open access: yesArthritis &Rheumatology, EarlyView.
Antiphospholipid syndrome (APS) is an autoimmune thromboinflammatory disease characterized by vascular thrombosis, pregnancy morbidity, and other manifestations driven by antiphospholipid autoantibodies. In this review, we present a clinical case that illustrates some diagnostic and therapeutic challenges in managing severe, relapsing APS ...
Thalia G. Newman, Jason S. Knight
wiley   +1 more source

Prognostic value of lupus anticoagulant and anti‐β2 glycoprotein I antibody in adverse pregnancy outcomes.

open access: yesArthritis &Rheumatology, Accepted Article.
Objective International criteria for antiphospholipid syndrome (APS) include lupus anticoagulant (LA), anticardiolipin (aCL) immunoglobulin (Ig) G and IgM, and anti‐β2‐glycoprotein I (β2GPI) IgG and IgM. However, evidence supporting their prognostic value or treatment efficacy in improving live birth rates is limited.
Megumi Nonobe   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy